GEN Exclusives

More »

GEN Poll

More »
Jun 05, 2012

Drug Repurposing

On June 12, NIH’s National Center for Advancing Translational Sciences (NCATS) will disclose its list of molecules for repurposing under a joint agency-industry pilot program. The initiative, Discovering New Therapeutic Uses for Existing Molecules, was announced last month. Pfizer, AstraZeneca, and Eli Lilly have agreed to allow researchers to study some of their shelved compounds, in hopes of advancing the understanding of various disease mechanism as well as finding new indications. Additional pharma companies may join, increasing the number of shelved compounds available for study.

How successful will NCATS' new pilot program prove in reviving at least some shelved compounds?

Not Very

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Sustainability in New Dietary Guidelines

Do you think that sustainability considerations should be incorporated into the new Dietary Guidelines for Americans?

More »